Gene editing (or genome editing) is the insertion, deletion or replacement of DNA at a specific site in the genome of an organism or cell.

It is usually achieved in the lab using engineered nucleases also known as molecular scissors.

In 2018, the global Gene Editing Tools market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Gene Editing Tools status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Gene Editing Tools development in United States, Europe and China.

The key players covered in this study

Thermofisher Scientific

CRISPR Therapeutics

Editas Medicine

NHGRI

Intellia Therapeutics

Merck KGaA

Horizo​​n

...

Market segment by Type, the product can be split into

Zinc finger nucleases (ZFNs)

Transcription Activator-Like Effector-based Nucleases (TALENs)

CRISPR-Cas system

Market segment by Application, split into

Sickle Cell Disease

Heart Disease

Diabetes

Alzheimer's Disease

Obesity

Others

Market segment by Regions/Countries, this report covers

United States

Europe

China

Japan

Southeast Asia

India

Central & South America

The study objectives of this report are:

To analyze global Gene Editing Tools status, future forecast, growth opportunity, key market and key players.

To present the Gene Editing Tools development in United States, Europe and China.

To strategically profile the key players and comprehensively analyze their development plan and strategies.

To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Gene Editing Tools are as follows:

History Year: 2014-2018

Base Year: 2018

Estimated Year: 2019

Forecast Year 2019 to 2025

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.